Emergent BioSolutions (United Kingdom)
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Emergent BioSolutions (United Kingdom), United Kingdom, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
81%
Total
Publications
70
Total Open
Publications
57
Total
Citations
732
Open Access
Percentage
81%
Total
Publications
70
Total Open
Publications
57
Total
Citations
732
Breakdown
Publisher Open
54%
Both
20%
Other Platform Open
7%
Closed
19%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 27%
14
Hybrid 19%
10
No Guarantees 54%
28
Other Platform Open
Institution 63%
12
Domain 37%
7
Other Internet 32%
6
Public 11%
2
Preprint 5%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 7 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 5 |
Europe PMC | Domain | 5 |
whiterose.ac.uk OAI-PMH Repository | Institution | 4 |
CiteSeer X | Other Internet | 3 |
Unknown Repository | Other Internet | 2 |
University of Birmingham - University of Birmingham Research Portal | Institution | 2 |
St George's University of London - St George's Online Research Archive | Institution | 2 |
Wiardi Beckman Foundation - Wiardi Beckman Foundation | Institution | 1 |
University of Minnesota, USA - AgEcon Search | Institution | 1 |